Tobacco News and Research

RSS

Study: Prenatal exposure to PAH leads to mental health problems in children

Exposure to common air pollutants during pregnancy may predispose children to problems regulating their thoughts, emotions, and behaviors later on, according to a new study led by researchers at the Columbia Center for Children's Environmental Health within Columbia University's Mailman School of Public Health and New York State Psychiatric Institute.

17 Mar 2016

Report: English schoolgirls' happiness drops as they hit teenage years

English schoolgirls are less satisfied with their lives than boys and feel more pressure to succeed at school – a report authored by University of Hertfordshire researchers has revealed.

16 Mar 2016

New research finds racial disparities in screening for lung cancer

New research from the Yale School of Public Health reveals that differences in smoking habits between African Americans and whites may lead to a disparity in screening for lung cancer.

16 Mar 2016

Cell-based tests reveal no activity in cells exposed to vapour from Vype ePen

A series of cell-based tests developed to compare the biological impact of cigarette smoke with e-cigarette vapour revealed no activity in cells exposed to vapour from Vype ePen, a commercially available e-cigarette.

16 Mar 2016

Population health research on cardiovascular health finds positive results

In 2009, Minneapolis Heart Institute Foundation, along with Allina Health, New Ulm Medical Center and the community of New Ulm, Minnesota, began a 10-year population health research project to learn if heart attacks and heart disease risk factors within a community could be decreased through community efforts. Results for the first five years have been released, and the initial findings are positive.

14 Mar 2016

California lawmakers raising smoking age to curb teen smoking

With California lawmakers voting this month to raise the minimum age to buy tobacco products from 18 to 21 years of age, questions are being raised about its impact. Although much of the discussion of the policy has centered on the 18 to 20 year-olds who will no longer be able to buy cigarettes, the real focus should be its potential to keep cigarettes away from high school students 14 to 17 years old, said John Billimek, a researcher with the Health Policy Research Institute in the UC Irvine School of Medicine.

14 Mar 2016

FDA approves Xalkori (crizotinib) to treat patients with ROS-1 positive NSCLC

The U.S. Food and Drug Administration today approved Xalkori (crizotinib) to treat people with advanced (metastatic) non-small cell lung cancer (NSCLC) whose tumors have an ROS-1 gene alteration. Xalkori is the first and only FDA approved treatment for patients with ROS-1 positive NSCLC.

13 Mar 2016

Is the global diet getting sweeter? An interview with Professor Barry Popkin

In the past, caloric sweeteners simply referred to cane sugar or beet sugar. However, over time we've created hundreds of different sugars that are all providing calories of the same amount, about four calories for every gram of the sugar. Some examples include corn syrups and more processed sweeteners like high fructose corn syrup.

10 Mar 2016

CWRU researcher to customize tobacco mosaic virus to treat human cancers

A Case Western Reserve University researcher has been awarded more than $3 million in federal and foundation grants to turn common plant viruses into cancer sleuths and search-and-destroy emissaries.

10 Mar 2016

HIV-positive individuals in Africa with certain genetic variant have lower chance of developing TB

In the first known discovery of its kind, a Case Western Reserve University School of Medicine-led team has found that HIV patients in Africa with a certain genetic variant have a 63-percent lower chance of developing tuberculosis than HIV patients without the genetic variant.

10 Mar 2016

Data traffic may help people better cope with pollution

Heavy city traffic contributes significantly to air pollution and health problems such as asthma, but University of Texas at Dallas researchers think another kind of traffic -- data traffic -- might help citizens better cope with pollution.

8 Mar 2016

FDA allows marketing of one-time use contact lens to help measure patient's intraocular pressure

The U.S. Food and Drug Administration today allowed marketing of a one-time use contact lens that may help practitioners identify the best time of day to measure a patient's intraocular pressure (IOP). Elevated IOP is often associated with the optic nerve damage that is characteristic of glaucoma.

7 Mar 2016

Idelvion approved for use in children and adults with Hemophilia B

The U.S. Food and Drug Administration today approved Idelvion, Coagulation Factor IX (Recombinant), Albumin Fusion Protein, for use in children and adults with Hemophilia B. Idelvion is the first coagulation factor-albumin fusion protein product to be approved, and the second Factor IX fusion protein product approved in the U.S. that is modified to last longer in the blood.

7 Mar 2016

Diets high in glycemic index linked to increased risk of lung cancer

Consuming a diet with a high glycemic index, a classification of how rapidly carbohydrates elevate blood sugar levels, was independently associated with an increased risk of developing lung cancer in non-Hispanic whites, according to a new epidemiologic study from The University of Texas MD Anderson Cancer Center.

4 Mar 2016

Stemina developing new screening method to diagnose autism

A University of Wisconsin-Madison spinoff is screening blood samples in an effort to develop a biologically based method to diagnose autism.

2 Mar 2016

FDA takes actions to help women, doctors better understand potential problems associated with Essure

The U.S. Food and Drug Administration announced today actions to provide important information about the risks of using Essure and to help women and their doctors be better informed of the potential complications associated with implantable forms of sterilization.

1 Mar 2016

FDA announces availability of $2 million for rare disease research

The U.S. Food and Drug Administration today announced the availability of $2 million in research grants to fund natural history studies in rare diseases. The aim is to collect data on how specific rare diseases progress in individuals over time so that knowledge can inform and support product development and approval. This will be the first time the FDA will provide funding through its Orphan Products Grants to conduct these types of studies for rare diseases.

1 Mar 2016